Ackman says Valeant-Allergan deal looks closer: Reuters
Investor William Ackman, who owns nearly 10 percent of Botox maker Allergan Inc, has said that the likelihood of Valeant Pharmaceuticals International Inc succeeding in its hostile takeover for Allergan increased on Monday, Reuters reported. Ackman's Pershing Square Capital Management and Valeant made a joint offer for Allergan in April, which the company has rejected. The spread on the deal was below 3 percent on Monday. Ackman said that was a drop of 50 basis points.
22 July 2014•1 min read
